Pediatric Program Summary Statistics Since the pediatric exclusivity program began, 283 Written Requests have been issued and 88 drugs have been granted exclusivity. Among these, only fluoxetine has been approved for the - Desvenlafaxine - Document - PDFSEARCH.IO

First Page	Meta Content
	Pediatric Program Summary Statistics Since the pediatric exclusivity program began, 283 Written Requests have been issued and 88 drugs have been granted exclusivity. Among these, only fluoxetine has been approved for the Add to Reading List Document Date: 2004-01-13 09:43:14 Open Document File Size: 18,83 KB Share Result on Facebook City Rockville / / IndustryTerm drug product / treatment of major depressive disorder / / MedicalCondition same disease / adult and pediatric depression / major depressive disorder / disease / disorder / adult depression / depression / pediatric depression / pediatric major depressive disorder / / Organization Division of Neuropharmacologic Drug Products / Center for Drug Evaluation and Research / office of Generic Drugs / Food and Drug Administration / Director Office / / / Position messenger / Regulatory Project Manager / Director / / Product fluoxetine / Insert Drug / / ProvinceOrState Maryland / / Technology pharmacokinetics / CGI / / URL www.fda.gov/cder/guidance/index.htm / www.fda.gov/cder/guidance/1852fnl.pdf / / SocialTag Organic chemistry Medicine Fluoxetine Antidepressant Paroxetine Investigational New Drug Food and Drug Administration Desvenlafaxine Escitalopram Chemistry

Pediatric Program Summary Statistics Since the pediatric exclusivity program began, 283 Written Requests have been issued and 88 drugs have been granted exclusivity. Among these, only fluoxetine has been approved for theAdd to Reading List